CG
Column Group Portfolio holdings
AUM
$65.7M
This Quarter Return
+28.28%
1 Year Return
-5.8%
3 Year Return
-15.66%
5 Year Return
–
10 Year Return
–
AUM
$258M
AUM Growth
+$258M
(-6.8%)
Cap. Flow
-$53.4M
Cap. Flow
% of AUM
-20.73%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
Surrozen
SRZN
|
$91.7K |
Top Sells
| 1 |
Revolution Medicines
RVMD
|
$53.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Revolution Medicines
RVMD
$7.1B
| $68.9M | 26.76% | 2,577,220 -2,000,620 | -44% | -$53.5M |
|
2
Tenaya Therapeutics
TNYA
$184M
| $55.2M | 21.42% | 9,400,290 | – | – |
|
3
RAPT Therapeutics
RAPT
$188M
| $50.1M | 19.45% | 2,680,621 | – | – |
|
|
NGM
4
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $47M | 18.23% | 18,136,735 | – | – |
|
5
Oric Pharmaceuticals
ORIC
$994M
| $27.7M | 10.75% | 3,568,181 | – | – |
|
|
6
Surrozen
SRZN
$104M
| $5.18M | 2.01% | 9,414,795 +166,666 | +2% | +$91.7K |
|
|
EFTR
7
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $3.58M | 1.39% | 4,309,329 | – | – |
|